Press Release
Category Added in a WPeMatico Campaign
-
Lucid Files Resale Prospectus Supplement
NEWARK, Calif., Feb. 24, 2026 /PRNewswire/ — Lucid Group, Inc. (Nasdaq: LCID), maker of the world’s most advanced electric vehicles,…
Read More » -
Resideo Announces Fourth Quarter and Full Year 2025 Financial Results and Initiates 2026 Outlook
Record high full year 2025 net revenue of $7.47 billion, up 11% year-over-year; ADI Global Distribution (“ADI”) and Products & Solutions…
Read More » -
ClearView successfully implements Equisoft’s cloud-based policy administration system
The implementation of Equisoft/manage policy admin system consolidates ClearView’s in-force portfolios onto a single modern platform, eliminating legacy system complexity…
Read More » -
Docusign Announces Timing of Fourth Quarter Fiscal 2026 Earnings Conference Call
SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ — Docusign (Nasdaq: DOCU) today announced that its fourth quarter fiscal 2026 results will be released…
Read More » -
Gen to Present at the Morgan Stanley Technology, Media & Telecom Conference
MOUNTAIN VIEW, Calif., Feb. 24, 2026 /PRNewswire/ — Gen Digital Inc. (NASDAQ: GEN), a global leader dedicated to powering Digital…
Read More » -
Verra Mobility Announces Fourth Quarter and Full Year 2025 Financial Results
Full year 2025 revenue of $979.1 million Full year 2025 net income of $136.6 million Full year 2025 net cash…
Read More » -
Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)
Data from the pivotal ENERGY trial showed IMAAVY® produced a rapid and durable hemoglobin responsea in wAIHA Currently no FDA-approved…
Read More » -
Revolve Group Announces Fourth Quarter and Full Year 2025 Financial Results
LOS ANGELES, Feb. 24, 2026 /PRNewswire/ — Revolve Group, Inc. (NYSE: RVLV), the next-generation fashion retailer for Millennial and Generation…
Read More » -
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
MENLO PARK, Calif., Feb. 24, 2026 /PRNewswire/ — GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer…
Read More »
